Gilead Sciences (GILD) FCF Payout Ratio (2009 - 2026)
Gilead Sciences' (GILD) quarterly FCF Payout Ratio came in at 0.43 in Q1 2026, down 29.79% YoY from 0.61 in Q1 2025, and up 34.08% on a QoQ basis from 0.32 in Q4 2025.
Gilead Sciences (GILD) FCF Payout Ratio (2009 - 2026) Analysis & Trends
Gilead Sciences (GILD) has 13 years of FCF Payout Ratio data on file, last reported at 0.43 in Q1 2026.
- Quarterly FCF Payout Ratio fell 29.79% year-over-year to 0.43 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.39 (down 1.62% YoY) and the FY2025 annual result came in at 0.42, up 10.95% from the prior year.
- FCF Payout Ratio advanced to 0.43 in Q1 2026, from 0.32 in the prior quarter.
- In the past five years, FCF Payout Ratio ranged from a high of 1.38 in Q2 2025 to a low of 0.23 in Q3 2024.
- A 5-year average of 0.52 and a median of 0.46 in 2024 frame the typical range for FCF Payout Ratio.
- The widest YoY moves for FCF Payout Ratio: up 88.65% in 2024, down 59.83% in 2024.
- Tracing GILD's FCF Payout Ratio over 5 years: stood at 0.39 in 2022, then rose by 24.08% to 0.48 in 2023, then retreated by 28.71% to 0.34 in 2024, then decreased by 7.56% to 0.32 in 2025, then surged by 34.08% to 0.43 in 2026.
- The last three FCF Payout Ratio figures came in at 0.43 (Q1 2026), 0.32 (Q4 2025), and 0.25 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 0.44 |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 0.99 |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | 0.48 |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 0.52 |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | -3.54 |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 0.39 |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | 0.30 |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 8.12 |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | - |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.30 |
| Mar 31, 2026 | 0.43 |
| Dec 31, 2025 | 0.32 |
| Sep 30, 2025 | 0.25 |
| Jun 30, 2025 | 1.38 |
| Mar 31, 2025 | 0.61 |
| Dec 31, 2024 | 0.34 |
| Sep 30, 2024 | 0.23 |
| Jun 30, 2024 | 0.82 |
| Mar 31, 2024 | 0.46 |
| Dec 31, 2023 | 0.48 |
| Sep 30, 2023 | 0.58 |
| Jun 30, 2023 | 0.43 |
| Mar 31, 2023 | 0.59 |
| Dec 31, 2022 | 0.39 |
| Sep 30, 2022 | 0.34 |
| Jun 30, 2022 | 0.56 |
| Mar 31, 2022 | 0.59 |
| Dec 31, 2021 | 0.29 |
| Sep 30, 2021 | 0.29 |